As elevated serum IL-6, IL-8, and IL-11 levels correlate to worse survival in cancer patients [30], we sought to measure IL-8 in both the serum and plasma samples in the NSCLC patients compared against normal volunteers. This evidence concerns the gene IL6 and non-small cell lung carcinoma.